Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
GSTT will lead the development of a national clinical metagenomics pilot service by deploying NHS developed laboratory, bioinformatic and clinical protocols along with Oxford Nanopore developed sequencing technology to a network of 30 NHS sites across the UK for the dual benefit of patient care and bio-surveillance.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Oxford Nanopore Technologies PLC | 05386273 | £13,960,966 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Awarded To | Status |
|---|---|---|---|
| Lot 1 | £13,960,966 initial term | active |
Government spending data: This supplier has received £144,544,480 in 170 payments (over £25k) from Department of Health and Social Care, UK Health Security Agency, DSIT, Guy's and St Thomas' NHS FT, Forestry Commission and 3 more public bodies (2020-05-06 to 2026-03-24). View full payment history →